CA9 anticorps (AA 113-143)
-
- Antigène Voir toutes CA9 Anticorps
- CA9 (Carbonic Anhydrase IX (CA9))
-
Épitope
- AA 113-143
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CA9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)
- Purification
- Purified
- Immunogène
- A portion of amino acids 113-143 from the human protein was used as the immunogen for this CA9 antibody.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product CA9 Anticorps primaire
-
-
- Indications d'application
- Titration of the CA9 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,Flow Cytometry: 1:10-1:50,Immunofluorescence: 1:10-1:50
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot the CA9 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
- Antigène
- CA9 (Carbonic Anhydrase IX (CA9))
- Autre désignation
- CA9 (CA9 Produits)
- Synonymes
- anticorps CA9, anticorps CAIX, anticorps Ca9, anticorps MN/CA9, anticorps MN, anticorps carbonic anhydrase 9, anticorps CA9, anticorps CAH9, anticorps Car9
- Sujet
- Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia. [UniProt]
- UniProt
- Q16790
-